{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Repeated analysis of variance measures will be used to analyze the quality of life data.","groups":[{"description":"Participants undergo Stereotactic Body Radiation Therapy in 5 fractions at least 40 hours apart over 10-18 days.\n\nThree dose levels: 40Gy and 45Gy all in 5 fractions. Each initial dose level will have 6 participants allocated to them. All participants are assessed at their 3 month post SBRT visit for Dose-Limiting Toxicities (DLTs). If ≤1 participant experiences a DLT, participants will be enrolled at the next dose level. If ≥3 participants experience a DLT, further accrual will be permanently halted and the study stopped. If 2 participants experience a DLT, then an additional 6 participants will be enrolled at the same dose level. In this setting, if ≤ 3/12 participants have a DLT, participants will be enrolled at the next dose level. If ≥ 4/12 participants have a DLT, further accrual will be permanently halted and the study stopped and 35 Gy will not be recommended as safe.\n\nThe dosing strategy for the 2nd (45Gy) cohort will be identical to the first.","id":"OG000","title":"Treatment (SBRT)"}],"populationDescription":"No patient was able to complete 3 month follow up to provide this QOL information","reportingStatus":"POSTED","timeFrame":"Up to 12 months","title":"Quality of Life Assessed by Functional Assessment of Cancer Therapy-Head and Neck Questionnaire","type":"SECONDARY"}